You are here: Industry Insights > AstraZeneca

News List

SII to sell AstraZeneca vaccine to private hospitals at Rs 600 per dose expresspharma
April 23, 2021
We would urge all corporate and private individuals to access the vaccines through the state facilitated machinery and private health systems, said the company.
Enhertu accepted via cancer drugs fund for HER2-positive breast cancer pharmatimes
April 21, 2021
The National Institute for Health and Care Excellence (NICE) has recommended AstraZeneca (AZ) and Daiichi Sankyo’s Enhertu for use within the cancer drugs fund (CDF) for the treatment of previously-treated HER2-positive metastatic breast cancer.
AstraZeneca Receives US Clearance of Proposed Acquisition of Alexion americanpharmaceuticalreview
April 19, 2021
AstraZeneca’s proposed acquisition of Alexion Pharmaceuticals, Inc (Alexion) has achieved an important step toward completion, having cleared US Federal Trade Commission review.
Greater risk of brain clots from COVID-19 compared with vaccines: UK researchers expresspharma
April 19, 2021
The study was based on a US health database, and so did not accrue new data on the risk of clots from AstraZeneca's vaccine directly, as the shot is not being rolled out there.
European Commission to not renew AstraZeneca and J&J vaccine contracts at expiry: Reports expresspharma
April 15, 2021
The European Commission is seeking clarification from J&J about the company’s “completely unexpected” announcement of delays in COVID-19 vaccine deliveries to the EU.
Update on the DARE-19 Phase III Trial for Farxiga in COVID-19 americanpharmaceuticalreview
April 13, 2021
AstraZeneca and Saint Luke’s Mid America Heart Institute announced high-level results of the primary analysis from the DARE-19 Phase III trial assessing the potential of Farxiga (dapagliflozin) to treat patients hospitalized with COVID-19 who are at ...
SII repays South Africa for COVID-19 vaccines that were not delivered expresspharma
April 12, 2021
The Serum Institute of India has fully refunded South Africa for the 500,000 doses of the COVID-19 vaccine, which were not delivered to the country after it decided not to use the vaccine because it was not effective against a new variant of the virus.
Biotech start-up Vaccitech files for US IPO expresspharma
April 12, 2021
Vaccitech owns the technology behind the COVID-19 vaccine developed by Oxford University and AstraZeneca.
Philippines halts use of AstraZeneca vaccine for people below 60 years pharmaceutical-technology
April 09, 2021
The Philippines Department of Health (DOH) has adopted the Food and Drug Administration’s (FDA) recommendation to temporarily put the use of the AstraZeneca Covid-19 vaccine on hold for individuals aged below 60 years.
COVAX has delivered vaccines to over 100 countries, despite supply hits: GAVI/WHO expresspharma
April 09, 2021
The COVAX vaccine facility has delivered nearly 38.4 million doses of COVID-19 vaccines to more than 100 countries and economies across six continents as of Thursday, six weeks after it began to roll out supplies, a statement said.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page